Karyopharm Therapeutics Inc reports results for the quarter ended in March - Earnings Summary

Karyopharm Therapeutics

08/05/2024 15:23

* Karyopharm Therapeutics Inc  KPTI.OQ  reported a quarterly
adjusted loss of 32 cents​​ per share for the quarter ended in
March, lower than the same quarter last year, when the company
reported EPS of -30 cents.  The mean expectation of
seven analysts for the quarter was for a loss of 33 cents per
share. Wall Street expected results to range from -37 cents
to -28 cents per share.
    * Revenue fell 14.4% to $33.13 million from a year ago;
analysts
expected $34.47 million. 
    * Karyopharm Therapeutics Inc's reported EPS for the quarter
was a
loss of 32 cents​.
    * The company reported a quarterly loss of $37.36 million.
    * Karyopharm Therapeutics Inc shares had fallen by 27.2%
this
quarter and gained 27.2% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 11.8%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Karyopharm
Therapeutics Inc is $5.00 
This summary was machine generated from LSEG data May 8 at 02:23
p.m. UTC. ​All figures in US dollars unless otherwise stated.
(For questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      -0.33          -0.32          Beat
 Dec. 31 2023      -0.31          -0.36          Missed
 Sep. 30 2023      -0.28          -0.30          Missed
 Jun. 30 2023      -0.34          -0.29          Beat